← Back to Patent Explorer
US3314852A Expired / Lapsed US ⏱️ 0.0 years remaining

Method of producing ataraxic, anticonvulsant activity and skeletal muscle relaxation

Assignee: Bristol Myers Co
•
Filing: 1963-10-04
•
Granted: 1967-04-18
•
Expires: 1983-10-04
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

No abstract record available.

Inventors

  • 👤 Daniel M Green
  • 👤 Russell F Krueger

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 12:55
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/435; A61K31/44; A61K31/21; A61K31/27; A61K31/38; A61K31/41; A61K31/42; A61K31/495; A61K31/505

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 179 words
A METHOD OF (A) INDUCING RELAXATION OF AT LEAST ONE OF SKELETAL MUSCLE IN ANIMALS SUFFERING FROM INVOLUNTARY CONTRACTIONS OF SKELETAL MUSCLE; AND (B) RELIEVING CONVULSIONS IN AN ANIMAL SUFFERING FROM THE SAME; AND (C) INDUCING ATARAXIA IN AN ANIMAL SUFFERING FROM NERVOUS TENSION; WHICH COMPRISES ORALLY ADMINISTERING TO SAID ANIMAL A THERAPEUTICALLY EFFECTIVE QUANTITY OF THE COMBINATION OF A SKELETAL MUSCLE RELAXANT AND AN ANTIHISTAMINE OR A PAHARMACEUTICALLY ACCEPTABLE NON-TOXIC ACID ADDITION SALT THEREOF IN THE RATIO OF 4 TO 32 PARTS OF SKELETAL MUSCLE RELAXANT PER PART OF ANTIHISTAMINE; SAID MUSCLE RELAXANT BEING SELECTED FROM THE GROUP CONSISTING OF GLYCERYL GUAIACOLATE, METHOCARBAMOYL, MEPHENESIN, MEPHENESIN CARBAMATE, CARIOPRODOL, EMYLCAMATE, MEPROBAMATE, HYDROXYPHENAMATE, STYRAMATE, CHLORZOXAZONE, ZOXAZOLAMINE, HYDROXYZINE AND PHENAGLYCODOL;L AND SAID ANTIHISTAMINE BEING SELECTED FROM THE GROUP CONSISTING OF TRIPELENNAMINE HCL, PYRILAMINE MALEATE, THONZYLAMINE HCL, METAPHENILENE HCL, METHJAPYRILENE HCL, CHLOROTHEN CITRATE, THENYLDIAMINE HCL, MECLIZINE HYDROCHLORIDE, CYCLIZINE HYDROCHLORIDE, CLORCYCLIZINE, PROMETHAZINE HYDROCHLORIDE, PYRATHIAZINE HYDROCHLORIDE, PHENIRAMINE MALEATE, CHLORPHENIRAMINE MALEATE, BROMMPHENIRAMINE MALEATE (D-ISOMER), TRIPROLIDONE HYDROCHLORIDE, PYRROBUTAMINE PHOSPHATE, DIPHENYLPYRALINE HYDROCHLORIDE, PHENINDAMINE TARTRATE, DIPHENHYDRAMINE, DIMENHYDRINATE, BROMODIPHENHYDRAMINE, DOXYLAMINE SUCCINATE, CARBINOXAMINE MALEATE, PHENYLLTOLOXAMINE DIHYDROGEN CITRATE AND PHENYLTOLOXAMINE DIHYDROGEN HYDROCHLORIDE.
Claim 2
Independent Claim 179 words
A METHOD OF (A) INDUCING RELAXATION OF AT LEAST ONE OF SKELETAL MUSCLE IN ANIMALS SUFFERING FROM INVOLUNTARY CONTRACTIONS OF SKELETAL MUSCLE; AND (B) RELIEVING CONVULSIONS IN AN ANIMAL SUFFERING FROM THE SAME; AND (C) INDUCING ATARAXIA IN AN ANIMAL SUFFERING FROM NERVOUS TENSION; WHICH COMPRISES ORALLY ADMINISTERING TO SAID ANIMAL A THERAPEUTICALLY EFFECTIVE QUANTITY OF THE COMBINATION OF A SKELETAL MUSCLE RELAXANT AND AN ANTIHISTAMINE OR A PAHARMACEUTICALLY ACCEPTABLE NON-TOXIC ACID ADDITION SALT THEREOF IN THE RATIO OF 4 TO 32 PARTS OF SKELETAL MUSCLE RELAXANT PER PART OF ANTIHISTAMINE; SAID MUSCLE RELAXANT BEING SELECTED FROM THE GROUP CONSISTING OF GLYCERYL GUAIACOLATE, METHOCARBAMOYL, MEPHENESIN, MEPHENESIN CARBAMATE, CARIOPRODOL, EMYLCAMATE, MEPROBAMATE, HYDROXYPHENAMATE, STYRAMATE, CHLORZOXAZONE, ZOXAZOLAMINE, HYDROXYZINE AND PHENAGLYCODOL;L AND SAID ANTIHISTAMINE BEING SELECTED FROM THE GROUP CONSISTING OF TRIPELENNAMINE HCL, PYRILAMINE MALEATE, THONZYLAMINE HCL, METAPHENILENE HCL, METHJAPYRILENE HCL, CHLOROTHEN CITRATE, THENYLDIAMINE HCL, MECLIZINE HYDROCHLORIDE, CYCLIZINE HYDROCHLORIDE, CLORCYCLIZINE, PROMETHAZINE HYDROCHLORIDE, PYRATHIAZINE HYDROCHLORIDE, PHENIRAMINE MALEATE, CHLORPHENIRAMINE MALEATE, BROMMPHENIRAMINE MALEATE (D-ISOMER), TRIPROLIDONE HYDROCHLORIDE, PYRROBUTAMINE PHOSPHATE, DIPHENYLPYRALINE HYDROCHLORIDE, PHENINDAMINE TARTRATE, DIPHENHYDRAMINE, DIMENHYDRINATE, BROMODIPHENHYDRAMINE, DOXYLAMINE SUCCINATE, CARBINOXAMINE MALEATE, PHENYLLTOLOXAMINE DIHYDROGEN CITRATE AND PHENYLTOLOXAMINE DIHYDROGEN HYDROCHLORIDE.

References Cited (Backward Citations)

CA608814A Cited
US2770649A Cited
US2863865A Cited
US2874190A Cited
US2928767A Cited
US2895960A Cited
US2992222A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1970-04-17 1970-10-17 1971-04-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1974-04-17 1974-10-17 1975-04-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1978-04-17 1978-10-17 1979-04-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag